Philippe Froguel
Prof Philippe Froguel is an expert in Endocrinology at Centre Hospitalier Universitaire de Lille (France). As of October 2026, ScienceLeadR ranks Philippe Froguel in the top 1% of experts worldwide for Obesity, Overnutrition and Overweight. Philippe Froguel has authored 974 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 3,404 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Genetics - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1987 - 2026
Number : 974
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| IRF7 signalling in tanycytes controls brain-body-immune response across the ovarian cycle. PMID 42881274 — cells, genes, communication, ovary, brain, immunity, leukocytes, sex | Nat Metab | 2026 | 0 |
| Insulin resistance and type 2 diabetes as allostatic responses to chronic nutrient excess. PMID 42413493 — diabetes mellitus, nutrients, insulin resistance, insulin, stress, physiological, insulin secretion, food, tissues, diabetes mellitus, type 2 | Cell Metab Top journal | 2026 | 2 |
| The case for primary prevention of obesity in the era of GLP-1 therapies. PMID 42403918 — glucagon-like peptide 1, drug therapy, obesity, primary prevention, therapeutics | Lancet Reg Health Eur | 2026 | 1 |
| Epigenetic landscapes in human pancreatic islets reveal distinct drivers for adaptation to age and type 2 diabetes. PMID 42236498 — diabetes mellitus, genes, islets of langerhans, insulin, biological science disciplines, stress, physiological, insulin secretion, diabetes mellitus, type 2 | Nat Commun | 2026 | 0 |
| The genetics of obesity: aetiology, prevention and therapy. PMID 41876875 — genetics, obesity, precision medicine, therapeutics | Nat Metab | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 9
LeadR Networks
Main global connection map